Ataraxis AI
@Ataraxis_AI
Followers
131
Following
11
Statuses
14
Transforming cancer care with AI precision medicine
New York, USA
Joined December 2022
Our team, including our CEO @JanWitowski, will be attending the 2025 J.P. Morgan Healthcare Conference #JPM2025 discussing our AI-native tools for treatment selection. Contact us to schedule a meeting:
1
1
6
Yesterday, @JanWitowski presented the results of our 8,161-patient validation study of Ataraxis Breast at San Antonio Breast Cancer Symposium #SABCS24. Great turnout for results showing Ataraxis AI-native tests outperform genomic assays and work in all breast cancer subtypes.
0
0
10
@ElisaAgostinett @SABCSSanAntonio @OncoAlert @BIGxResearch @Carmela_surgery @virologyst @Lucarecco @E_de_Azambuja @ALEDIGNUS12 @EtienneB66 @ZoppoliGabriele @JulesBordet Congratulations! 🎉🥳
0
0
1
We are at #SABCS24 next week: @JanWitowski will present results of the Ataraxis Breast validation study—first time in public. This 8161 patient study showed our AI predicts recurrence&survival in all breast cancer patients, and with ⬆️accuracy than SoC genomic test. Come meet us
0
2
11
We are coming to NeurIPS! @joecappadona will present results of our novel approach to training foundation models for digital pathology. This research goes beyond simply scaling model/data size, and led us to develop Kestrel, the model behind Ataraxis Breast. Come see us!
0
4
8
RT @kjgeras: Anyone looking for a full stack engineer position? This is a great job in a great startup. You need t…
0
2
0
Ataraxis is growing! We're now hiring for commercial, technical, medical and ops roles:
We are hiring at Ataraxis! Jobs: The mission: apply advanced AI to one of the hardest problems in healthcare—optimizing treatment and predicting patient outcomes Looking for problem-solvers across all roles who want to build something meaningful
0
1
6
“If you don’t benefit from chemotherapy, you want to avoid it.” Our CEO @JanWitowski shared with Forbes' @TheAlexKnapp how Ataraxis Breast enables providers to recommend more precise, effective treatments—helping patients avoid unnecessary chemotherapy—and more.
EXCLUSIVE: Startup Ataraxis, which emerged from stealth Thursday, has developed a model that can predict the risk severity of breast cancer up to 30% more accurately than current tests.
0
3
12
Ataraxis AI raised $4m last year in a round co-led by @Giant_Ventures and @obviousvc. Ataraxis Breast and Kestrel were built by a small and hyperfocused ex-NYU team supported by oncology and AI pioneers, including our advisor, @ylecun. More info at
0
2
15
0
0
1